| 000 | 01649nam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025914.0 | ||
| 008 | 090804s2009 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2009.Gh.F | ||
| 100 | 0 | _aGhada Ahmed Zidan | |
| 245 | 1 | 0 |
_aFormulation and bioavailability of rapidly dispersible famotidine tablets / _cGhada Ahmed Zidan ; Supervised Ahmed Abdelbary , Nagwa Ali Sabry , Ahmed Hassan Elshafeey |
| 246 | 1 | 5 | _aصياغة ودراسة الاتاحة الحيوية لاقراص الفموتيدين سريعة الذوبان |
| 260 |
_aCairo : _bGhada Ahmed Zidan , _c2009 |
||
| 300 |
_a263 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aFamotidine is a potent H2-receptor antagonist most commonly used by elderly patients. Orodispersible tablets (ODT) are gaining popularity over conventional tablets due to their convenience and suitability for patients having dysphagia. The purpose of this study is to prepare famotidine ODT using the economic direct-compression method | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAc-Di-Sol bioawailability | |
| 653 | 4 | _aL-HPC | |
| 653 | 4 | _aOrodispersible tablets | |
| 700 | 0 |
_aAhmed Hassan Elshafeey , _eSupervisor |
|
| 700 | 0 |
_aGhada Ahmed Zidan , _eSupervisor |
|
| 700 | 0 |
_aNagwa Ali Sabry , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c23283 _d23283 |
||